Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02385292 · ClinicalTrials.gov registry record · NA
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
A NA study, sponsored by Oculeve.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02385292 is a NA study that has completed, run by Oculeve. The registered enrollment target is 23 participants.
The verdict
NCT02385292, a NA study, has completed, sponsored by Oculeve.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The objectives of this study are: * To compare the change in levels of tear proteins and inflammatory mediators pre and post administration between the intranasal and extranasal applications * To compare the goblet cell count following application between the intranasal and extranasal applications * To compare fluorescein tear clearance with the application of the device intranasally and extranasally applications
Interventions
- DEVICE Oculeve Intranasal Lacrimal Neurostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-05-31 |
| Est. Completion | 2016-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02385292
The ClinicalTrials.gov registry entry for NCT02385292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oculeve, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oculeve Intranasal Lacrimal Neurostimulator is the first listed.
NCT02385292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02385292 about?
NCT02385292 is a clinical study titled "Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation". The objectives of this study are: * To compare the change in levels of tear proteins and inflammatory mediators pre and post administration between the intranasal and extranasal applications * To compare the goblet cell count following application between the intranasal and extranasal applications ...
What is the current status of trial NCT02385292?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-05-31. Estimated completion is 2016-03-31.
What interventions are being tested in trial NCT02385292?
The interventions under investigation include: Oculeve Intranasal Lacrimal Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT02385292?
This trial is sponsored by Oculeve, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.